ACC
BIIB icon

Accident Compensation Corp’s Biogen BIIB Stock Holding History

Accident Compensation Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,200
Closed -$356K – 112
2019
Q4 		$356K Hold
1,200
– – 0.08% 109
2019
Q3 		$279K Hold
1,200
– – 0.07% 108
2019
Q2 		$281K Hold
1,200
– – 0.07% 113
2019
Q1 		$284K Buy
+1,200
New +$378K 0.07% 113

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Accident Compensation Corp's BIIB Position: Q1 2020 in Review

Accident Compensation Corp sold out of Biogen (BIIB) in Q1 2020, closing a stake of 1,200 shares — an estimated $356K sold.

Accident Compensation Corp first reported a position in BIIB in Q1 2019 and held it in 4 quarters. The position peaked at $356K in Q4 2019. 1,099 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Accident Compensation Corp reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Accident Compensation Corp sold 1,200 Biogen shares in Q1 2020, an estimated $356K.
  • Accident Compensation Corp first reported a position in Biogen in Q1 2019 and held it in 4 quarters.
  • Accident Compensation Corp's Biogen position peaked at $356K in Q4 2019.
  • 1,099 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Accident Compensation Corp's 13F filing for Q1 2020, filed 14 May 2020.